
Lance W. Rider
Examiner (ID: 8345, Phone: (571)270-1337 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 662 |
| Issued Applications | 193 |
| Pending Applications | 1 |
| Abandoned Applications | 470 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5415787
[patent_doc_number] => 20090041674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-12
[patent_title] => 'TARGETED IRON OXIDE NANPARTICLES'
[patent_app_type] => utility
[patent_app_number] => 12/280321
[patent_app_country] => US
[patent_app_date] => 2007-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7022
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20090041674.pdf
[firstpage_image] =>[orig_patent_app_number] => 12280321
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/280321 | TARGETED IRON OXIDE NANPARTICLES | Feb 13, 2007 | Abandoned |
Array
(
[id] => 5120747
[patent_doc_number] => 20070142462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-21
[patent_title] => 'Method of Treating Cancer'
[patent_app_type] => utility
[patent_app_number] => 11/671199
[patent_app_country] => US
[patent_app_date] => 2007-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 13773
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20070142462.pdf
[firstpage_image] =>[orig_patent_app_number] => 11671199
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/671199 | Method of Treating Cancer | Feb 4, 2007 | Abandoned |
Array
(
[id] => 5079261
[patent_doc_number] => 20070122485
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-31
[patent_title] => 'Organic compounds'
[patent_app_type] => utility
[patent_app_number] => 11/650701
[patent_app_country] => US
[patent_app_date] => 2007-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4455
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20070122485.pdf
[firstpage_image] =>[orig_patent_app_number] => 11650701
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/650701 | Organic compounds | Jan 7, 2007 | Abandoned |
Array
(
[id] => 5367040
[patent_doc_number] => 20090304599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'Protein Nanoparticles and the Use of the Same'
[patent_app_type] => utility
[patent_app_number] => 12/097560
[patent_app_country] => US
[patent_app_date] => 2006-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5447
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0304/20090304599.pdf
[firstpage_image] =>[orig_patent_app_number] => 12097560
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/097560 | Protein Nanoparticles and the Use of the Same | Dec 19, 2006 | Abandoned |
Array
(
[id] => 5100853
[patent_doc_number] => 20070184115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-09
[patent_title] => 'Modified release formulations of tramadol and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/640494
[patent_app_country] => US
[patent_app_date] => 2006-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 140064
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20070184115.pdf
[firstpage_image] =>[orig_patent_app_number] => 11640494
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/640494 | Modified release formulations of tramadol and uses thereof | Dec 17, 2006 | Abandoned |
Array
(
[id] => 4882689
[patent_doc_number] => 20080257021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-23
[patent_title] => 'Method of Making Dried Particles'
[patent_app_type] => utility
[patent_app_number] => 12/097788
[patent_app_country] => US
[patent_app_date] => 2006-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2633
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20080257021.pdf
[firstpage_image] =>[orig_patent_app_number] => 12097788
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/097788 | Method of Making Dried Particles | Dec 14, 2006 | Abandoned |
Array
(
[id] => 5040165
[patent_doc_number] => 20070092447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-26
[patent_title] => 'CONTRAST AGENT FOR COMBINED MODALITY IMAGING AND METHODS AND SYSTEMS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 11/565786
[patent_app_country] => US
[patent_app_date] => 2006-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 12733
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20070092447.pdf
[firstpage_image] =>[orig_patent_app_number] => 11565786
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/565786 | CONTRAST AGENT FOR COMBINED MODALITY IMAGING AND METHODS AND SYSTEMS THEREOF | Nov 30, 2006 | Abandoned |
Array
(
[id] => 5182490
[patent_doc_number] => 20070053834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-08
[patent_title] => 'Radioligands for the TRP-M8 receptor and methods therewith'
[patent_app_type] => utility
[patent_app_number] => 11/595006
[patent_app_country] => US
[patent_app_date] => 2006-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10212
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20070053834.pdf
[firstpage_image] =>[orig_patent_app_number] => 11595006
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/595006 | Radioligands for the TRP-M8 receptor and methods therewith | Nov 7, 2006 | Abandoned |
Array
(
[id] => 4964895
[patent_doc_number] => 20080107715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-08
[patent_title] => 'PHARMACEUTICAL CONTAINING FOOD COMPOSITIONS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 11/556644
[patent_app_country] => US
[patent_app_date] => 2006-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7133
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20080107715.pdf
[firstpage_image] =>[orig_patent_app_number] => 11556644
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/556644 | PHARMACEUTICAL CONTAINING FOOD COMPOSITIONS AND USES THEREOF | Nov 2, 2006 | Abandoned |
Array
(
[id] => 4663192
[patent_doc_number] => 20080254099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-16
[patent_title] => 'Pharmaceutical Compositions Comprising Polymeric Binders with Non-Hydrolysable Covalent Bonds and Their Use in Treating Celiac Disease'
[patent_app_type] => utility
[patent_app_number] => 12/093423
[patent_app_country] => US
[patent_app_date] => 2006-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9569
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20080254099.pdf
[firstpage_image] =>[orig_patent_app_number] => 12093423
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/093423 | Pharmaceutical compositions comprising polymeric binders with non-hydrolysable their use in treating celiac disease | Oct 26, 2006 | Issued |
Array
(
[id] => 7550693
[patent_doc_number] => 08063026
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-22
[patent_title] => 'Method of palliating lower urinary tract infections by treatment with mannan oligosaccharides'
[patent_app_type] => utility
[patent_app_number] => 11/544244
[patent_app_country] => US
[patent_app_date] => 2006-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4577
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/063/08063026.pdf
[firstpage_image] =>[orig_patent_app_number] => 11544244
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/544244 | Method of palliating lower urinary tract infections by treatment with mannan oligosaccharides | Oct 5, 2006 | Issued |
Array
(
[id] => 4943696
[patent_doc_number] => 20080081021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-03
[patent_title] => 'Manganese-enhanced magnetic resonance imaging of neurons using electrical stimulation'
[patent_app_type] => utility
[patent_app_number] => 11/540264
[patent_app_country] => US
[patent_app_date] => 2006-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8738
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20080081021.pdf
[firstpage_image] =>[orig_patent_app_number] => 11540264
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/540264 | Manganese-enhanced magnetic resonance imaging of neurons using electrical stimulation | Sep 28, 2006 | Abandoned |
Array
(
[id] => 5056324
[patent_doc_number] => 20070059246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-15
[patent_title] => 'Use of bile acid derivatives conjugated with metal ion chelated complexes for the diagnostic assessment of microvascular permeability'
[patent_app_type] => utility
[patent_app_number] => 11/527710
[patent_app_country] => US
[patent_app_date] => 2006-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9197
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20070059246.pdf
[firstpage_image] =>[orig_patent_app_number] => 11527710
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/527710 | Use of bile acid derivatives conjugated with metal ion chelated complexes for the diagnostic assessment of microvascular permeability | Sep 26, 2006 | Abandoned |
Array
(
[id] => 5215690
[patent_doc_number] => 20070104771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-10
[patent_title] => 'Transdermal galantamine delivery system'
[patent_app_type] => utility
[patent_app_number] => 11/525696
[patent_app_country] => US
[patent_app_date] => 2006-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11999
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20070104771.pdf
[firstpage_image] =>[orig_patent_app_number] => 11525696
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/525696 | Transdermal galantamine delivery system | Sep 21, 2006 | Abandoned |
Array
(
[id] => 5130690
[patent_doc_number] => 20070207087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-06
[patent_title] => 'Cycloalkyl triamine pentacarboxylate as ligands for paramagnetic metal complexes'
[patent_app_type] => utility
[patent_app_number] => 11/524771
[patent_app_country] => US
[patent_app_date] => 2006-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8640
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20070207087.pdf
[firstpage_image] =>[orig_patent_app_number] => 11524771
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/524771 | Cycloalkyl triamine pentacarboxylate as ligands for paramagnetic metal complexes | Sep 20, 2006 | Issued |
Array
(
[id] => 4859026
[patent_doc_number] => 20080267876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-30
[patent_title] => 'Nanoparticles for Targeted Delivery of Active Agent'
[patent_app_type] => utility
[patent_app_number] => 12/067510
[patent_app_country] => US
[patent_app_date] => 2006-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 17091
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20080267876.pdf
[firstpage_image] =>[orig_patent_app_number] => 12067510
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/067510 | Nanoparticles for Targeted Delivery of Active Agent | Sep 19, 2006 | Abandoned |
Array
(
[id] => 5074768
[patent_doc_number] => 20070014743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-18
[patent_title] => 'Subunguicide, and method for treating onychomycosis'
[patent_app_type] => utility
[patent_app_number] => 11/523508
[patent_app_country] => US
[patent_app_date] => 2006-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4623
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20070014743.pdf
[firstpage_image] =>[orig_patent_app_number] => 11523508
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/523508 | Subunguicide, and method for treating onychomycosis | Sep 18, 2006 | Abandoned |
Array
(
[id] => 5034137
[patent_doc_number] => 20070098676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-03
[patent_title] => 'FUNCTIONALLY DIVERSE MACROMOLECULES AND THEIR SYNTHESIS'
[patent_app_type] => utility
[patent_app_number] => 11/532342
[patent_app_country] => US
[patent_app_date] => 2006-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18348
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20070098676.pdf
[firstpage_image] =>[orig_patent_app_number] => 11532342
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/532342 | FUNCTIONALLY DIVERSE MACROMOLECULES AND THEIR SYNTHESIS | Sep 14, 2006 | Abandoned |
Array
(
[id] => 5135672
[patent_doc_number] => 20070077301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-05
[patent_title] => 'Venlafaxine osmotic device formulation'
[patent_app_type] => utility
[patent_app_number] => 11/532186
[patent_app_country] => US
[patent_app_date] => 2006-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 18976
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20070077301.pdf
[firstpage_image] =>[orig_patent_app_number] => 11532186
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/532186 | Venlafaxine osmotic device formulation | Sep 14, 2006 | Abandoned |
Array
(
[id] => 10620630
[patent_doc_number] => 09339559
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-17
[patent_title] => 'Targeted contrast agents and methods for targeting contrast agents'
[patent_app_type] => utility
[patent_app_number] => 11/530398
[patent_app_country] => US
[patent_app_date] => 2006-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 12
[patent_no_of_words] => 12547
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11530398
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/530398 | Targeted contrast agents and methods for targeting contrast agents | Sep 7, 2006 | Issued |